Mechanisms of Very Late DES Thrombosis by OCT

Original Title: Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography. Reference: Masanori Taniwaki et al. Circulation. 2016 Feb 16;133(7):650-60.

 

The physiopathological mechanisms behind DES thrombosis have not been fully described yet. The potential causes behind this adverse event were assessed using optical computed tomography (OCT).

Between August 2010 and December 2014, 64 patients with instent very late thrombosis were included as part of an international OCT registry.
Very late thrombosis occurred at median 4.7 years after the original procedure (range 3.1 to 7.5 years).

After restoration of flow, OCT pullbacks were performed to analyze 38 first generation DES and 20 new generation DES; a possible cause was observed 98% of times.

The most frequent findings were strut malapposition (34.5%), neo atherosclerosis (27.6%), uncovered struts (12.1%) and stent underexpansion (6.9%).

Uncovered struts and malapposition were more frequent in thrombosed regions vs. non thrombosed.

Maximum stent length with absence or malapposed intimal covering (3.40 mm vs 1.29 mm; p<0.001) was a very strong predictor of thrombosis, but not malapposition distance (distance separating struts from intimal covering).

The combination of malapposition and absence of covering was consistent in both DES generations.

Conclusion
The most frequent causes of very late thrombosis were malapposition, neoatherosclerosis, uncovered struts and underexpansion, across first and new generation DES.

The maximal length of malapposed or uncovered struts showed the highest correlation with very late thrombosis.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....